BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6222471)

  • 1. Regulation of the binding of C3-coated particles to human lymphocytes by human complement component H.
    Fontaine M; Daveau M; Gilbert D
    Scand J Immunol; 1983 May; 17(5):463-70. PubMed ID: 6222471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells.
    Scheiner O; Schulz TF; Schmid HU; Lambris JD; Alsenz J; Dierich MP
    Immunobiology; 1983 Aug; 165(2):211-24. PubMed ID: 6226591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibodies against factor H to investigate the role of a membrane-associated protein antigenically related to H in C3b-receptor function.
    Schulz TF; Scheiner O; Alsenz J; Lambris JD; Dierich MP
    J Immunol; 1984 Jan; 132(1):392-8. PubMed ID: 6197451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD; Dobson NJ; Ross GD
    J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multifunctional role of C3: structural analysis of its interactions with physiological ligands.
    Lambris JD; Müller-Eberhard HJ
    Mol Immunol; 1986 Nov; 23(11):1237-42. PubMed ID: 2950317
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Baker PJ; Rosse WF
    J Immunol; 1983 Nov; 131(5):2484-9. PubMed ID: 6226743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF; Prince GM; Gaither TA; Frank MM
    J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta 1H stimulates mouse-spleen B lymphocytes as demonstrated by increased thymidine incorporation and formation of B cell blasts.
    Hammann KP; Raile A; Schmitt M; Mussel HH; Peters H; Scheiner O; Dierich MP
    Immunobiology; 1981; 160(3-4):289-301. PubMed ID: 6459990
    [No Abstract]   [Full Text] [Related]  

  • 19. C3b acceptors on macrophages: inhibition of Fc gamma-receptor-mediated phagocytosis by acceptor-bound C3b.
    Fábry Z; Erdei A; Gergely J
    Immunol Lett; 1983 Jun; 6(6):287-91. PubMed ID: 6226600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.